š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This multi-center, randomized, double blind, parallel-group, placebo-contro...
Status
Completed
Location
Multiple Locations
Start Date
2010-12
Trial ID
NCT01192906
Treatments Being Tested
This randomized, double-blind, placebo-controlled, dose-escalating study wi...
Status
Completed
Location
Multiple Locations
Start Date
2005-11
Trial ID
NCT01636492
Treatments Being Tested
This randomized, double-blind, placebo- and active-controlled, parallel gro...
Status
Completed
Location
Multiple Locations
Start Date
2011-02
Trial ID
NCT01234779
Treatments Being Tested
The goal of this expanded access program is to provide bitopertin to patien...
Status
Available
Location
University of Miami Miller School of Medicine
Start Date
TBD
Trial ID
NCT07603401
Treatments Being Tested
This study will determine the efficacy and safety of RO4917838 in patients ...
Status
Completed
Location
Multiple Locations
Start Date
2008-03
Trial ID
NCT00616798
Treatments Being Tested
This randomized, placebo- and active-controlled, crossover study will evalu...
Status
Completed
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01438749
This open-label, single-dose, parallel group study will assess the pharmaco...
Status
Completed
Location
Multiple Locations
Start Date
2011-06
Trial ID
NCT01356550
Treatments Being Tested
This Phase 3, multi-center, randomized, double blind, parallel-group, place...
Status
Completed
Location
Clinical Innovtions Inc
Start Date
2010-11
Trial ID
NCT01192880
Treatments Being Tested
This is a Phase 2, multi-center, double-blind, placebo-controlled, parallel...
Status
Completed
Location
University of Alabama Hospital
Start Date
2022-10-31
Trial ID
NCT05308472
This multicenter, randomized, double-blind, parallel-group, placebo-control...
Status
Completed
Location
Excell Research
Start Date
2012-12-31
Trial ID
NCT01674361
Treatments Being Tested